Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9Melanoma 4Neoplasms 3Multiple Myeloma 3Skin Neoplasms 2Polycystic Ovary Syndrome 2Venous Thromboembolism 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Stem Cell Transplant Complications 1Skin Toxicity 1Resectable Pancreatic Ductal Adenocarcinoma 1Renal Insufficiency 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Obesity 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Meningioma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Inflammation 1

Interventions

Ropivacaine 2Magnesium Sulfate 2Fentanyl 2trimebutine 3-thiocarbamoylbenzenesulfonate 1ramosetron 1Transdermal Patch 1Tablets 1Surveys and Questionnaires 1Psilocybin 1Pregabalin 1Nefopam 1Morphine 1Lidocaine 1Levobupivacaine 1Ketoprofen 1Ketamine 1Injections, Subcutaneous 1High-Energy Shock Waves 1Control Groups 1Capsaicin 1Bupivacaine 1Botulinum Toxins, Type A 1Anesthetics, Local 1Analgesics, Opioid 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Agnosia × Tablets × Clear all
NCT04162379 2020-03-10

Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol

Mansoura University

Phase 2 Completed
39 enrolled

Cancer Pain, Agnosia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡